Trifecta™ GT Post Market Clinical Follow-up

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 358 participants.

Also called NCT03016169

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 358 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03016169
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Canada, Estonia, France, Germany, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03016169. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-09 (actual); primary completion 2023-04-25 (actual). Results posted on 2024-05-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trifecta™ GT Post Market Clinical Follow-up
Condition
Aortic Valve Disease
Condition
Aortic Valve Disorder
Intervention (Device)
Trifecta GT (Glide Technology) Valve
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct03016169
Content hash
9e9b23c773c243f17d4a3e400cbc35b17dad52f7aff81cc3f0534397192b5df8